Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.
作者信息
Brittain Evan L, Hemnes Anna R
机构信息
Vanderbilt University Medical Center, Nashville, TN.
出版信息
Circ Res. 2022 Apr 29;130(9):1362-1364. doi: 10.1161/CIRCRESAHA.122.321168. Epub 2022 Apr 28.
Abstract
摘要
相似文献
1
Introduction to Review Series on Pulmonary Vascular Disease and Right Ventricular Heart Failure.肺血管疾病与右心室心力衰竭综述系列介绍
Circ Res. 2022 Apr 29;130(9):1362-1364. doi: 10.1161/CIRCRESAHA.122.321168. Epub 2022 Apr 28.
2
Chronic Right Heart Failure: Expanding Prevalence and Challenges in Outpatient Management.慢性右心衰竭：门诊管理中患病率的上升及面临的挑战。
Heart Fail Clin. 2018 Jul;14(3):413-423. doi: 10.1016/j.hfc.2018.03.007.
3
The Right Heart-Pulmonary Circulation Unit in Systemic Hypertension.右心-肺循环单位与系统性高血压。
Heart Fail Clin. 2018 Jul;14(3):247-253. doi: 10.1016/j.hfc.2018.02.002.
4
Right Ventricular to Pulmonary Circulation Coupling Comes to the Front Line in Acute Heart Failure With Preserved Ejection Fraction.右心室与肺循环耦联在射血分数保留的急性心力衰竭中成为前沿问题。
Circ Cardiovasc Imaging. 2020 Nov;13(11):e012001. doi: 10.1161/CIRCIMAGING.120.012001. Epub 2020 Nov 17.
5
Ventricular Assist Device Use in Patients With Single-Ventricle Circulation.心室辅助装置在单心室循环患者中的应用。
Can J Cardiol. 2022 Jul;38(7):1086-1099. doi: 10.1016/j.cjca.2022.03.012. Epub 2022 Mar 18.
6
The Right Heart-Pulmonary Circulation Unit: Physiopathology.右心-肺循环单元：病理生理学。
Heart Fail Clin. 2018 Jul;14(3):237-245. doi: 10.1016/j.hfc.2018.02.001.
7
[Management of right ventricular failure in pulmonary vascular diseases].[肺血管疾病中右心室衰竭的管理]
Rev Mal Respir. 2020 Feb;37(2):171-179. doi: 10.1016/j.rmr.2019.07.012. Epub 2020 Feb 13.
8
Pulmonary Hypertension and Heart Failure: A Dangerous Liaison.肺动脉高压与心力衰竭：危险的联姻。
Heart Fail Clin. 2018 Jul;14(3):297-309. doi: 10.1016/j.hfc.2018.02.006.
9
10
Pulmonary vascular and cardiac impairment in interstitial lung disease.间质性肺疾病中的肺血管和心脏损害
Eur Respir Rev. 2017 Jan 17;26(143). doi: 10.1183/16000617.0053-2016. Print 2017 Jan.
引用本文的文献
1
Advances in diagnosis and patient profiling in pulmonary arterial hypertension for precision medicine.肺动脉高压精准医学中诊断与患者特征分析的进展
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251367312. doi: 10.1177/17534666251367312. Epub 2025 Aug 29.
2
Chronic Mercury Exposure Triggers Vascular Remodeling and Impaired Vasoconstriction in Small Intrapulmonary Arteries.慢性汞暴露引发肺内小动脉血管重塑及血管收缩功能受损。
Cardiovasc Toxicol. 2025 Aug 13. doi: 10.1007/s12012-025-10047-x.
3
Pulmonary vascular disease, environmental pollution, and climate change.肺血管疾病、环境污染与气候变化。
Pulm Circ. 2024 Jun 26;14(2):e12394. doi: 10.1002/pul2.12394. eCollection 2024 Apr.
4
Tensions in Taxonomies: Current Understanding and Future Directions in the Pathobiologic Basis and Treatment of Group 1 and Group 3 Pulmonary Hypertension.分类学中的紧张局势：1 型和 3 型肺动脉高压的病理生物学基础和治疗的当前理解和未来方向。
Compr Physiol. 2023 Jan 30;13(1):4295-4319. doi: 10.1002/cphy.c220010.
本文引用的文献
1
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.理解左心疾病所致肺动脉高压的病理生理学。
Circ Res. 2022 Apr 29;130(9):1382-1403. doi: 10.1161/CIRCRESAHA.122.319967. Epub 2022 Apr 28.
2
Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.利用大数据推进肺动脉高压的治疗和认识。
Circ Res. 2022 Apr 29;130(9):1423-1444. doi: 10.1161/CIRCRESAHA.121.319969. Epub 2022 Apr 28.
3
Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.新型肺动脉及右心影像学方法
Circ Res. 2022 Apr 29;130(9):1445-1465. doi: 10.1161/CIRCRESAHA.121.319990. Epub 2022 Apr 28.
4
Group 3 Pulmonary Hypertension: From Bench to Bedside.第 3 组肺动脉高压：从基础到临床。
Circ Res. 2022 Apr 29;130(9):1404-1422. doi: 10.1161/CIRCRESAHA.121.319970. Epub 2022 Apr 28.
5
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.肺动脉高压和右心衰竭的最新动物模型。
Circ Res. 2022 Apr 29;130(9):1466-1486. doi: 10.1161/CIRCRESAHA.121.319971. Epub 2022 Apr 28.
6
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.肺动脉高压的新突变和发病机制：疾病发病机制中的进展和困惑。
Circ Res. 2022 Apr 29;130(9):1365-1381. doi: 10.1161/CIRCRESAHA.122.320084. Epub 2022 Apr 28.
7
Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease.特发性肺纤维化相关肺动脉高压患者应用吸入曲前列尼尔治疗
N Engl J Med. 2021 Jan 28;384(4):325-334. doi: 10.1056/NEJMoa2008470. Epub 2021 Jan 13.
8
Haemodynamic definitions and updated clinical classification of pulmonary hypertension.血流动力学定义和肺动脉高压的最新临床分类。
Eur Respir J. 2019 Jan 24;53(1). doi: 10.1183/13993003.01913-2018. Print 2019 Jan.
9
Cournand and Richards: The Nobel Prize.
Ann Am Thorac Soc. 2018 Feb;15(Suppl 1):S1-S3. doi: 10.1513/AnnalsATS.201710-773KV.
10
Disproportionate Right Ventricular Dysfunction and Poor Survival in Group 3 Pulmonary Hypertension.3型肺动脉高压患者右心室功能失调及生存率低下情况不均衡
Am J Respir Crit Care Med. 2018 Jun 1;197(11):1496-1499. doi: 10.1164/rccm.201712-2405LE.
Zotero 插件